Learning scenario
Joanna, 43, comes to the counter for advice. She has suffered with eczema in the past, and she has found that her skin is particularly dry at the moment. Joanna explains that it can sometimes become itchy and looks scaly, so she tries to hide it. She wants to manage it now to try and prevent it from getting worse. Through your consultation you identify that she currently uses an ointment when her symptoms flare up, but she finds it quite greasy and messy to use.
What advice could you give to Joanna?
INCORRECT
Joanna should be advised to use an emollient (even when the skin is clear) to help hydrate and restore her skin barrier
INCORRECT
A topical corticosteroid should not be used to manage dry skin. Joanna should use an emollient to help hydrate and restore her skin barrier
CORRECT
People’s preferences vary and she may not have found the right regime to suit her. You could recommend a basic daily regime of an emollient wash and lotion to help manage her dry skin.
INCORRECT
There are no signs to refer to the GP, such as an infection. Self-management of dry skin is advised by the NHS, and Joanna should feel enabled by the pharmacy team to manage her dry skin confidently
REFERENCES
1. NHS England (2018), Conditions for which over the counter items should not routinely be prescribed in primary care: findings of consultation and next steps, NHS Board Paper. Available at: www.england.nhs.uk/wp-content/uploads/2018/03/08-pb-29-03-2018-otc-fully-combined.pdf
2. Schofield J et al. (2009), Skin conditions in the UK: a health needs assessment
3. Andy Tisman (2008), Driving the self care agenda, PAGB Annual Review, IMS Health. Available at: www.pagb.co.uk/content/uploads/2016/06/Driving-the-selfcare-agenda-AndyTisman.pdf
4. Sharma S. et al. (2017). Anatomy, Skin (Integument), Epidermis. Available at: https://www.ncbi.nlm.nih.gov/books/NBK470464/
5. Harwood et al (2017), Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on cutaneous ceramides, in a human skin organ culture model, Biochim Biophys Acta, Elsevier, Issue 1859, DOI 10.1016/j.bbamem.2017.03.016
6. Coderch et al (2003), Ceramides and skin function, Am J Clin Dermatol, 2003;4(2):107-29, DOI 10.2165/00128071-200304020-00004. Available at: www.ncbi.nlm.nih.gov/pubmed/12553851
7. Purnamawati et al (2017), The role of moisturizers in addressing various kinds of dermatitis: a review, Clin Med Res, 15(3-4): 75–87, DOI 10.3121/cmr.2017.1363. Available at: www.ncbi.nlm.nih.gov/pmc/articles/PMC5849435/
8. Grice EA, Segre JA (2011), The skin microbiome, Nature reviews Microbiology, 2011;9(4):244-253.
9. National Eczema Association. Eczema in Skin of Color: what you need to know. Available at https://nationaleczema.org/blog/eczema-in-skin-of-color/
10. NHS Health A to Z: Overview atopic eczema, NHS. Available at: www.nhs.uk/conditions/atopic-eczema/
11. National Eczema Society, Emollient prescribing for eczema: information for patients. Available at: https://eczema.org/wp-content/uploads/Emollientprescribing-guidance-for-patients-and-primary-care-prescribers.pdf
12. National Eczema Society, Emollients. Available at: www.eczema.org/emollients
13. Wallo et al (2012), Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis, Journal of Drugs in Dermatology, Vol. 11(7)
14. Grais ML (1953), AMA Arch Derm Syphilol 1953;68:402–407.
15. Van Onselen J (2011), Dry skin conditions: an evidence-based focus on natural oatmeal emollients, Primary Health Care, Vol. 21
16. Kurtz ES and Wallo W (2007), Colloidal oatmeal: History, chemistry and clinical properties, Journal of Drugs in Dermatology, Vol. 6
17. Fowler et al (2012), New learnings on the clinical benefits of colloidal oatmeal in atopic dermatitis, The Dermatologist
18. Johnson & Johnson. Data on file
19. Johnson & Johnson. Data on file
20. NICE Guidance, Quality statement 2: Stepped approach to management, NICE clinical guideline 57. Available at: www.nice.org.uk/guidance/qs44/chapter/Quality-statement-2-Stepped-approach-to-management
21. NHS Health A to Z: Complications atopic eczema, NHS. Available at: www.nhs.uk/conditions/atopic-eczema/complications/
Online references last accessed November 2022
This communication has been approved by the NPA. The NPA will have no liability to any person or entity with liability, loss or damage caused or alleged to have been caused directly or indirectly by information therein. The NPA is not responsible for the content of any non-NPA websites mentioned in this programme or for the accuracy of any information found there. The fact that a website, organisation or product is mentioned in the programme does not mean that the NPA either approves of it or endorses it.
